Explore our database of over 4000 laboratory markers.
Search and Understand 4000+ Biomarkers
Optimal range: 0 - 32.9 mg/L
The Kappa Light Chain, Free, Urine test is a highly specialized diagnostic tool used extensively in the field of medical diagnostics to detect and monitor a range of hematological disorders, particularly multiple myeloma and other plasma cell dyscrasias. This test specifically measures the level of free kappa light chains present in the urine, which are small protein fragments produced by plasma cells, a type of white blood cell. Elevated levels of kappa light chains in urine can be an indicator of multiple myeloma, a cancer of plasma cells, or other related disorders. The test is crucial in both the initial diagnostic process and the ongoing monitoring of these conditions, playing a vital role in the early detection and effective management of diseases characterized by abnormal plasma cell growth.
Optimal range: 0.26 - 1.65 Ratio
Free light chains will normally be present in the blood at low levels, with a kappa/lambda ratio of approximately 0.26 to 1.65 for individuals with normal kidney function.
Excess production of free kappa or lambda chains can alter this ratio. Monoclonal free light chains are found in serum of patients with multiple myeloma, Waldenstrom's macroglobulinemia, mu-heavy chain disease, primary amyloidosis, light chain deposition disease, monoclonal gammopathy of undetermined significance, and lymphoproliferative disorders.
When the test is used to monitor a known plasma cell disorder, a decrease in the quantity of excess light chain and a more normal kappa/lambda ratio may indicate a response to treatment.
Decreased free light chains with a normal kappa/lambda ratio may be seen with a disorder that suppresses bone marrow cell production.
Optimal range: 0 - 8.69 Ratio
The Kappa/Lambda Free Ratio (Urine) test is a sophisticated diagnostic assessment extensively utilized in the field of medical diagnostics, particularly in hematology and oncology. This test plays a pivotal role in the detection and management of multiple myeloma and other plasma cell disorders. It measures the ratio of kappa to lambda free light chains in urine. Free light chains are small protein segments produced by plasma cells in the bone marrow. In a healthy individual, kappa and lambda light chains are produced in a relatively balanced ratio. However, an imbalance in this ratio, as indicated by the Kappa/Lambda Free Ratio (Urine) test, can be a significant marker for various hematological conditions.
Optimal range: 0 - 0 mcg/mg creatinine
Alpha-Ketoisovalerate requires Vitamin B1, B5, lipoic acid, B2, and B3 (in descending order of significance) to be metabolized. As your food is broken down, specific compounds are formed at steps that require B vitamin assistance. a-Ketoisovalerateis one of these compounds. If these nutrients are insufficient, the keto acids may build up in the urine.
Optimal range: 0 - 0.001 Units
What are ketones?
Ketones are produced when the body burns fat for energy. Normally, your body gets the energy it needs from carbohydrates in your diet. But stored fat is broken down and ketones are made if your diet does not contain enough carbohydrate to supply the body with sugar (glucose) for energy or if your body can't use blood sugar (glucose) properly.
Having some ketones in your urine is normal. However, high ketone levels in urine may be a sign of too much acid in your body (ketoacidosis). The most common and life-threatening type of ketoacidosis is a complication of diabetes called diabetic ketoacidosis (DKA). If left untreated DKA can cause damage to organs and even death. This is why it is important to know the signs of ketonuria and when to check your ketone levels with a urine or blood test.
Optimal range: 0.3 - 1.5 ELISA Index
Elevated antibody levels can be clinically significant — while the antibodies themselves don’t destroy anything, they do trigger an inflammatory response that can cause significant destruction of tissue and resulting symptoms. This response is not necessarily dependent on antibody levels. However, an equivocal result may mean you are just beginning to exhibit an immune reaction, so this is an important time to take measures to support the body in damping immune reactivity.
Reference range: Very Low, Low, Moderate, High, Very High
LEARN MOREReference range: Strong reaction, Moderate reaction, No reaction
LEARN MOREOptimal range: 0.2 - 1.7 ELISA Index
LEARN MOREReference range: Very Low, Low, Moderate, High, Very High
LEARN MOREOptimal range: 0 - 1.3 ELISA Index
Klebsiella are gram-negative, facultative anaerobic, non-motile, rod-shaped bacteria. Array 12 assesses immune reactivity to Klebsiella pneumoniae, Klebsiella oxytoca and Klebsiella pneumoniae uti.
Reference range: NG - No Growth, NP - Non-Pathogen, PP - Potential Pathogen, P - Pathogen
Klebsiella are non-motile, Gramnegative rods that belong to the Enterobacteriaceae family.
Klebsiella bacteria are considered commensal but act as opportunistic bacteria in the GI tract.
Klebsiellais a leading cause of hospital-acquired infections.
Klebsiella is part of the normal intestinal flora.
Reference range: No Growth, 1+, 2+, 3+, 4+
Klebsiella spp. are gram-negative bacilli belonging to the Enterobacteriaceae family and closely related to the genera Enterobacter and Serratia. Klebsiella spp. are considered dysbiotic in the amount of 3 - 4 +. Klebsiella spp. are widely distributed in nature and in the gastrointestinal tract of humans. In humans, they may colonize the skin, oral cavity, pharynx, or gastrointestinal tract. Regarded as normal flora in many parts of the colon, intestinal tract and biliary tract, the gut is the main reservoir of opportunistic strains.
This bacteria has the potential to cause intestinal, lung, urinary tract, and wound infections, but overgrowth of Klebsiella spp. is commonly asymptomatic.
Optimal range: 0 - 5 x10^5 CFU/g
Klebsiella spp. are gram-negative bacilli belonging to the Enterobacteriaceae family and closely related to the genera Enterobacter and Serratia. Klebsiella spp. are considered dysbiotic in the amount of 3 - 4 +. Klebsiella spp. are widely distributed in nature and in the gastrointestinal tract of humans. In humans, they may colonize the skin, oral cavity, pharynx, or gastrointestinal tract. Regarded as normal flora in many parts of the colon, intestinal tract and biliary tract, the gut is the main reservoir of opportunistic strains.
This bacteria has the potential to cause intestinal, lung, urinary tract, and wound infections, but overgrowth of Klebsiella spp. is commonly asymptomatic.
Optimal range: 0 - 2.5 Units
Gram-negative bacteria in the Proteobacteria phylum. Common residents of the oral cavity and respiratory tract. May cause diarrhea, gas, abdominal pain, and bloating; Common after long-term antibiotic use; May release histamine in the gut; High levels may indicate increased intestinal inflammatory activity.
Optimal range: 0 - 50000 Units
Gram-negative bacteria in the Proteobacteria phylum. Common residents of the oral cavity and respiratory tract. May cause diarrhea, gas, abdominal pain, and bloating; Common after long-term antibiotic use; May release histamine in the gut; High levels may indicate increased intestinal inflammatory activity.
Reference range: Normal, Abnormal
When K. pneumoniae enters the urinary tract, it can lead to a UTI. A UTI can affect any part of the urinary system, including the urethra, kidneys, bladder, and ureters. Symptoms include a strong, frequent need to urinate, burning sensation during urination, pelvic pain, and cloudy, bloody, or strong-smelling urine. Women are at a greater risk for UTIs than men.
As a gram-negative, encapsulated, non-motile bacterium, it is inherently resistant to multiple antibiotics, making its role in UTIs particularly concerning. Klebsiella pneumoniae primarily inhabits the gastrointestinal tract but can become opportunistic in immunocompromised individuals or when introduced into typically sterile areas like the urinary tract. UTIs caused by this bacterium are often more complicated to treat due to its resistance to commonly used antibiotics, such as penicillins and cephalosporins.
Klebsiella pneumoniae ssp (subspecies) is known for its thick, prominent capsule, which is a key virulence factor. This capsule helps the bacteria evade the host's immune response, allowing it to establish infection more effectively. When it infects the urinary tract, it can lead to a range of symptoms, from mild bladder infections (cystitis) to severe kidney infections (pyelonephritis). The presence of this bacterium in the urinary tract can be particularly dangerous in hospital settings, where it may cause nosocomial infections.
The treatment of UTIs caused by Klebsiella pneumoniae often requires the use of more potent antibiotics, such as carbapenems or aminoglycosides, which are reserved for more severe infections due to their potential side effects and the risk of further promoting antibiotic resistance.
Reference range: No Growth, 1+, 2+, 3+, 4+
Klebsiella spp. are gram-negative bacilli belonging to the Enterobacteriaceae family and closely related to the genera Enterobacter and Serratia. Klebsiella spp. are widely distributed in nature and in the gastrointestinal tract of humans. In humans, they may colonize the skin, oral cavity, pharynx, or gastrointestinal tract.